Key Announcements: Hengrui Medicine (01276): RSS0393 Emulsion Approved for Clinical Trials Longqi Technology (09611) Plans to Invest $41 Million to Subscribe to an Overseas Cloud Computing Power Investment Fund China Antibody-B (03681) to Present Preclinical Research on Anti-CGC Antibody (hC2) at the 2026 SID Annual Meeting Dongpeng Beverage (09980): Chengdu Base Signs "State-owned Construction Land Use Right Transfer Contract" with Chengdu Wenjiang District Planning and Natural Resources Bureau Hengrui Medicine (01276) Subsidiary Receives "Drug Clinical Trial Approval Notice" for SHR-3079 Injection from the National Medical Products Administration
Operational Performance: Huahong Semiconductor (01347) Releases Q1 Results: Shareholder Attributable Profit of $20.9 Million, Up 458.1% Year-on-Year China Gold International (02099) Releases Q1 Results: Quarterly Net Profit Surpasses $200 Million for the First Time, Setting a New Record SMIC (00981) Announces Q1 Results: Company Owner's Attributable Profit of Approximately $197 Million, Up 14.2% Sequentially and 5% Year-on-Year Ali Health (00241) Annual Adjusted Net Profit Reaches RMB 23.262 Billion, Up 19.3% Year-on-Year
Comments